In Vitro Diagnostics (IVDs) Market Report

In Vitro Diagnostics (IVDs) Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Feb 10, 2020
  • PAGES：137
  • REPORT CODE：GMM467663
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide In Vitro Diagnostics (IVDs) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.9% during the forecast period.

    This report presents the market size and development trends by detailing the In Vitro Diagnostics (IVDs) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the In Vitro Diagnostics (IVDs) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of In Vitro Diagnostics (IVDs) industry and will help you to build a panoramic view of the industrial development.

    In Vitro Diagnostics (IVDs) Market, By Type:

    • Immunology

    • Hematology

    • Clinical Chemistry

    • Molecular Diagnostics

    • Coagulation

    • Microbiology

    • Others

    In Vitro Diagnostics (IVDs) Market, By Application:

    • Hospital

    • Laboratory

    • Home Care

    • Others

    Some of the leading players are as follows:

    • Roche Diagnostics

    • Becton

    • Dickinson and Company

    • Sysmex Corporation

    • Danaher Corporation

    • Bio-Rad Laboratories

    • Johnson and Johnson

    • Thermo Fisher Scientific

    • Abbott Laboratories

    • Siemens Healthcare

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 In Vitro Diagnostics (IVDs) Market: Technology Type Analysis

    • 4.1 In Vitro Diagnostics (IVDs) Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 In Vitro Diagnostics (IVDs) Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Immunology

      • 4.3.2 Hematology

      • 4.3.3 Clinical Chemistry

      • 4.3.4 Molecular Diagnostics

      • 4.3.5 Coagulation

      • 4.3.6 Microbiology

      • 4.3.7 Others

    5 In Vitro Diagnostics (IVDs) Market: Product Analysis

    • 5.1 In Vitro Diagnostics (IVDs) Product Market Share Analysis, 2018 & 2026

    • 5.2 In Vitro Diagnostics (IVDs) Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 In Vitro Diagnostics (IVDs) Market: Application Analysis

    • 6.1 In Vitro Diagnostics (IVDs) Application Market Share Analysis, 2018 & 2026

    • 6.2 In Vitro Diagnostics (IVDs) Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Laboratory

      • 6.3.3 Home Care

      • 6.3.4 Others

    7 In Vitro Diagnostics (IVDs) Market: Regional Analysis

    • 7.1 In Vitro Diagnostics (IVDs) Regional Market Share Analysis, 2018 & 2026

    • 7.2 In Vitro Diagnostics (IVDs) Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Roche Diagnostics

      • 9.1.1 Roche Diagnostics Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Becton

      • 9.2.1 Becton Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Dickinson and Company

      • 9.3.1 Dickinson and Company Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Sysmex Corporation

      • 9.4.1 Sysmex Corporation Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Danaher Corporation

      • 9.5.1 Danaher Corporation Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Bio-Rad Laboratories

      • 9.6.1 Bio-Rad Laboratories Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Johnson and Johnson

      • 9.7.1 Johnson and Johnson Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Thermo Fisher Scientific

      • 9.8.1 Thermo Fisher Scientific Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Abbott Laboratories

      • 9.9.1 Abbott Laboratories Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Siemens Healthcare

      • 9.10.1 Siemens Healthcare Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 81 Figures and 128 Tables)

    • Figure Immunology In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Hematology In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Clinical Chemistry In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Molecular Diagnostics In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Coagulation In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Microbiology In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Others In Vitro Diagnostics (IVDs) market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Laboratory market, 2015 - 2026 (USD Million)

    • Figure Home Care market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America In Vitro Diagnostics (IVDs) market, by country, 2015 - 2026 (USD Million)

    • Table North America In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table North America In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table North America In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table U.S. In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table U.S. In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Canada In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Canada In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Europe In Vitro Diagnostics (IVDs) market, by country, 2015 - 2026 (USD Million)

    • Table Europe In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Europe In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Europe In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table U.K. In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table U.K. In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Germany In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Germany In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table France In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table France In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Italy In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Italy In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Spain In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Spain In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific In Vitro Diagnostics (IVDs) market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table China In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table China In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Japan In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Japan In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table India In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table India In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Latin America In Vitro Diagnostics (IVDs) market, by country, 2015 - 2026 (USD Million)

    • Table Latin America In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Latin America In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Latin America In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Brazil In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Brazil In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Mexico In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Mexico In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Argentina In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Argentina In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table MEA In Vitro Diagnostics (IVDs) market, by country, 2015 - 2026 (USD Million)

    • Table MEA In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table MEA In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table MEA In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table South Africa In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table South Africa In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria In Vitro Diagnostics (IVDs) market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria In Vitro Diagnostics (IVDs) market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria In Vitro Diagnostics (IVDs) market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Becton Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Dickinson and Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sysmex Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Danaher Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson and Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Siemens Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US